A novel detergent-like compound developed by UAB researchers that blocks HIV and HSV viruses from entering cells could have the same effect against the virus that causes COVID-19. The team is exploring the compound’s potential with a commercialization grant from the U.S. Economic Development Administration.

UAB’s Benevolent Fund has been working in overdrive to meet the needs of Blazers and Birmingham residents. Making, restarting or increasing a monthly pledge via payroll deduction can help continue its work.

UAB’s respiratory therapy program, developed at University Hospital, moved to the university’s School of Community and Allied Health Resources in 1970. Today, UAB Medicine continues to hire respiratory therapists, who are essential during the COVID-19 pandemic.

In addition to the health, dental and vision benefits, UAB employees also will have the option to select insurance to cover accidents and identity theft and/ or participate in a pet-care discount program during open enrollment Oct. 23-Nov. 9.

Colleagues explain say retiring Animal Resources Program Director Samuel Cartner, DVM, Ph.D., has helped shape the institution’s research.

Benjamin Larimer, Ph.D., has received a five-year, $1.5-million New Innovator Award grant to develop a PET imaging test that identifies patients most likely to benefit from immunotherapy.

Using extensive testing, diagnosis and clinical data from across the Deep South, this project will be the first to analyze multiple dimensions of inequality to clarify contributions to COVID-19 disparities.